Jason Adair
About Jason Adair
Jason Adair is the Chief Business Officer with a background in corporate development, business development, marketing, and operations in the pharmaceutical industry.
Jason Adair - Chief Business Officer
Jason Adair is the Chief Business Officer, responsible for leading strategic business development initiatives. Throughout his career, he has demonstrated expertise in corporate development, marketing, and operations across various roles in the pharmaceutical industry. His leadership has significantly contributed to the growth and success of the organizations he has worked with.
Jason Adair at BioCryst Pharmaceuticals
At BioCryst Pharmaceuticals, Jason Adair served as the Executive Director of Corporate Development. During his tenure, he spearheaded business development efforts, notably leading the commercial launch and subsequent partnering of the company’s first FDA-approved drug. His strategic guidance was instrumental in positioning BioCryst for future growth and innovation in the pharmaceutical sector.
Jason Adair's Career at MedImmune and AstraZeneca
Jason Adair held various increasing responsibility roles at MedImmune and its parent company AstraZeneca. His positions in business development, marketing, and operations allowed him to influence the company's direction and expand its market presence. His comprehensive experience within these organizations equipped him with a deep understanding of the pharmaceutical industry, from product development to market deployment.
Jason Adair's Early Career and Military Service
Before transitioning into the pharmaceutical industry, Jason Adair worked as an analytical chemist at Syngenta, gaining hands-on experience in the chemical sciences. Additionally, he served as an officer in the United States Army, where he developed leadership and strategic planning skills that have informed his business acumen.
Jason Adair's Education and Academic Background
Jason Adair holds an M.B.A. from the Tuck School of Business at Dartmouth College, which has equipped him with advanced business management and strategic skills. He also obtained a B.S. in Chemistry from Wake Forest University, providing him with a strong foundational knowledge of the sciences that supports his work in the pharmaceutical industry.